Related Experiment Video
Updated: May 30, 2026

08:12
Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
Published on: March 14, 2019
Colorectal cancers with microsatellite instability display unique miRNA profiles
Francesc Balaguer1, Leticia Moreira, Juan Jose Lozano
1Department of Internal Medicine, Division of Gastroenterology, Charles A. Sammons Cancer Center and Baylor Research Institute, Baylor University Medical Center, Dallas, Texas 75246, USA.
Summary
Colorectal cancer (CRC) shows distinct microRNA (miRNA) profiles. Unique miRNA signatures differentiate Lynch syndrome, sporadic MSI, and MSS CRC, aiding diagnosis and treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRNAs) are small noncoding RNAs crucial in cancer development.
- miRNA expression patterns can distinguish various cancer types.
- Understanding miRNA signatures in colorectal cancer (CRC) subtypes is vital.
Purpose of the Study:
- To investigate global miRNA expression profiles in different colorectal cancer (CRC) groups based on microsatellite instability (MSI).
- To identify specific miRNA signatures differentiating Lynch syndrome, sporadic MSI, and microsatellite-stable (MSS) CRC.
- To develop a miRNA-based diagnostic tool for CRC subtypes.
Main Methods:
- Genome-wide miRNA expression profiling using miRNA microarrays on 54 CRC tissues and 20 normal colonic tissues.
- Analysis included Lynch syndrome (n=22), sporadic MSI (n=13), and MSS (n=19) CRC.
- A miRNA-based predictor was developed and validated using quantitative reverse transcriptase PCR on an independent set of MSI-positive samples.
Main Results:
- A panel of nine miRNAs significantly distinguished CRC tissues from normal colonic mucosa (error rate = 0.04).
- Lynch syndrome tumors exhibited a distinct miRNA profile compared to sporadic MSI tumors.
- Key differentiating miRNAs included miR-622, miR-1238, and miR-192; a predictor successfully differentiated MSI types.
Conclusions:
- Colorectal cancer tissues possess unique miRNA expression profiles compared to normal tissues.
- Distinct miRNA signatures identified for Lynch syndrome, sporadic MSI, and MSS CRC offer new insights into colorectal carcinogenesis.
- These findings may advance the diagnosis, prognosis, and therapeutic strategies for colorectal cancer.
Related Concept Videos
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
lncRNA - Long Non-coding RNAs
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...

